The U.S. Food and Drug Administration (FDA) has granted the nod for the release and emergency use of revamped Covid-19 mRNA vaccines tailored for the 2023-2024...
This Thursday, Moderna shared upbeat outcomes from its recent clinical studies of its revised Covid-19 vaccine. This adaptation aims to tackle emerging virus mutations, notably the...
As the autumn season looms over the U.S., presenting the perennial challenge of respiratory diseases, attention is being diverted to EG.5 – a fresh derivative of...
